Aspect Partners’s Zimmer Biomet ZBH Stock Holding History

Aspect Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.95K	Sell	104 -5	-5%	-$438	﹤0.01%	301
2026 Q1	$9.86K	Hold	109	–	–	﹤0.01%	265
2025 Q4	$9.8K	Buy	109 +7	+7%	+$664	﹤0.01%	274
2025 Q3	$10K	Hold	102	–	–	﹤0.01%	299
2025 Q2	$9.3K	Sell	102 -2	-2%	-$193	﹤0.01%	293
2025 Q1	$11.8K	Hold	104	–	–	0.01%	243
2024 Q4	$11K	Hold	104	–	–	0.01%	269
2024 Q3	$11.2K	Hold	104	–	–	0.01%	257
2024 Q2	$11.3K	Hold	104	–	–	0.01%	246
2024 Q1	$13.7K	Hold	104	–	–	0.01%	231
2023 Q4	$12.7K	Buy	+104	New	+$11.6K	0.01%	229

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Aspect Partners's ZBH Position: Q2 2026 in Review

Aspect Partners reduced its Zimmer Biomet (ZBH) stake by 4.6% in Q2 2026, selling an estimated $438 and leaving 104 shares worth $8.95K. The position accounts for ﹤0.01% of the portfolio, ranked #301.

Aspect Partners first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.7K in Q1 2024. 125 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Aspect Partners held 104 shares of Zimmer Biomet worth $8.95K as of Q2 2026.
Aspect Partners sold 5 Zimmer Biomet shares in Q2 2026, an estimated $438.
Zimmer Biomet made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #301 holding.
Aspect Partners first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
Aspect Partners's Zimmer Biomet position peaked at $13.7K in Q1 2024.
125 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.